Search
SOLACI Congress
HomeStructural heart diseaseValvular Aortic valve

Valvular Aortic valve

View Category

Structural heart disease

ESC 2025 | DOUBLE-CHOICE: Anesthesia Strategies and Self-Expanding Valves in TAVI

TAVI has become the predominant treatment for severe aortic stenosis. The DOUBLE-CHOICE trial analyzed two key aspects:...
Dr. Omar Tupayachi -
Learn More
Pharmacology

Can Colchicine Reduce Post-TAVR Conduction Disturbances?

Courtesy of Dr. Juan Manuel Pérez. Partly caused by perioperative inflammation, conduction disturbances often follow TAVR. Colchicine, known...
Dr. Juan Manuel Pérez -
Learn More
Structural heart disease

TRIPLACE Registry: Conduction Disorders Following Transcatheter Tricuspid Valve Replacement

Tricuspid regurgitation (TR) has become increasingly common and has been associated to hospitalization for cardiac failure and...
Dr. Carlos Fava -
Learn More
Structural heart disease

Conduction Disorders in TAVR: Is Colchicine Useful?

TAVR has shown significant benefit and is increasingly used in severe aortic stenosis, especially in lower risk...
Dr. Carlos Fava -
Learn More
Structural heart disease

Post TAVR Conduction Disturbances: Same Day Permanent Pacemaker Implantation

TAVR has consolidated as standard of care for aortic stenosis. In recent years, high volume centers have...
Dr. Omar Tupayachi -
Learn More
Structural heart disease

Conduction Disorders Before TAVR: What Is Their Impact?

Transcatheter aortic valve replacement (TAVR) has become an established treatment for severe aortic stenosis and is now...
Dr. Carlos Fava -
Learn More
Structural heart disease

Balloon-Expandable Myval Valve Four-Year Outcomes

The expanding indication of transcatheter aortic valve replacement (TAVR) to younger patients or those at lower surgical...
Dr. Omar Tupayachi -
Learn More
Coronary disease

Coronary Events Following TAVI: A Registry

Between 30 and 70% of patients undergoing transcatheter aortic valve replacement (TAVR) present coronary artery disease (CAD)....
Dr. Andrés Rodríguez -
Learn More

SOLACI is the reference organization for Latin American cardiovascular interventionism.

Last News

Coronary Perforations and Use of Covered Stents: Safe and Effective Long-Term Strategy?

Dr. Omar Tupayachi - 0
Coronary perforations remain one of the most serious complications of percutaneous coronary intervention (PCI), especially in cases of Ellis ruptures type III. In these...

Is it really necessary to monitor all patients after TAVR?

Dr. Juan Manuel Pérez - 0
Conduction disorders (CD) after transcatheter aortic valve replacement (TAVR) are a frequent complication and may lead to the need for permanent pacemaker implantation (PPI)....

Is it really necessary to monitor all patients after TAVR?

Dr. Juan Manuel Pérez - 0
Conduction disorders (CD) after transcatheter aortic valve replacement (TAVR) are a frequent complication and may lead to the need for permanent pacemaker implantation (PPI)....

Institutional News

Watch Again: Pulmonary Embolism in 2025 — Risk Stratification and Novel Therapeutic Approaches

solaci - 0
Our webinar “Pulmonary Embolism in 2025: Risk Stratification and Novel Therapeutic Approaches” is now available to watch. The session took place on November 25,...

Watch Again: SELUTION – Sirolimus-Eluting Balloon for De Novo Coronary Lesions – New Evidence and Clinical Perspectives

solaci - 0
Our webinar “SELUTION: Sirolimus-Eluting Balloon for De Novo Coronary Lesions – New Evidence and Clinical Perspectives”, held on November 19, 2025 via Zoom with...

25/11 – SOLACI Webinar: Pulmonary Embolism in 2025 – Risk Stratification and Novel Therapeutic Approaches

solaci - 0
The Latin American Society of Interventional Cardiology invites you to participate in a new virtual scientific event titled “Pulmonary Embolism (PE) in 2025: Risk...

Access

Adolfo Alsina 2653 · Piso 2H · CABA · Buenos Aires · Argentina · (5411) 4954 7173 · info@solaci.org · solaci.org · Terms of Use -Privacy Policy